86 FR 180 pg. 52444 - Foreign-Trade Zone (FTZ) 7—Mayaguez, Puerto Rico; Authorization of Production Activity; AbbVie Ltd. (Pharmaceutical Products), Barceloneta, Puerto Rico

Type: NOTICEVolume: 86Number: 180Page: 52444
Docket number: [B-41-2021]
FR document: [FR Doc. 2021-20376 Filed 9-20-21; 8:45 am]
Agency: Commerce Department
Sub Agency: Foreign-Trade Zones Board
Official PDF Version:  PDF Version
Page: 52444

[top] page 52444

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-41-2021]

Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; AbbVie Ltd. (Pharmaceutical Products), Barceloneta, Puerto Rico

On May 19, 2021, AbbVie Ltd., submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 7I, in Barceloneta, Puerto Rico.

The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (86 FR 28540, May 27, 2021). On September 16, 2021, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.

Dated: September 16, 2021.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2021-20376 Filed 9-20-21; 8:45 am]

BILLING CODE 3510-DS-P